【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Coronary Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Coronary Disease 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Coronary Disease Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
Cordis Corporation 40
Clinical Trial Overview of Cordis Corporation 40
Hoffmann-La Roche Inc. 41
Clinical Trial Overview of Hoffmann-La Roche Inc. 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
TCA Cellular Therapy, LLC 45
Clinical Trial Overview of TCA Cellular Therapy, LLC 45
Schering-Plough Limited 46
Clinical Trial Overview of Schering-Plough Limited 46
AbbVie Inc. 47
Clinical Trial Overview of AbbVie Inc. 47
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Sanofi 49
Clinical Trial Overview of Sanofi 49
Acusphere, Inc. 50
Clinical Trial Overview of Acusphere, Inc. 50
The Medicines Company 51
Clinical Trial Overview of The Medicines Company 51
Scios Inc. 52
Clinical Trial Overview of Scios Inc. 52
Sarepta Therapeutics, Inc. 53
Clinical Trial Overview of Sarepta Therapeutics, Inc. 53
CardioDx, Inc. 54
Clinical Trial Overview of CardioDx, Inc. 54
Resverlogix Corp. 55
Clinical Trial Overview of Resverlogix Corp. 55
Minvasys 56
Clinical Trial Overview of Minvasys 56
Clinical Trial Overview of Top Universities / Institutes / Hospitals 57
Deutsches Herzzentrum Munchen 57
Clinical Trial Overview of Deutsches Herzzentrum Munchen 57
Brigham and Women’s Hospital 59
Clinical Trial Overview of Brigham and Women’s Hospital 59
Medical University of Vienna 60
Clinical Trial Overview of Medical University of Vienna 60
The University of Edinburgh 61
Clinical Trial Overview of The University of Edinburgh 61
Seoul National University Hospital 62
Clinical Trial Overview of Seoul National University Hospital 62
University of Nebraska 63
Clinical Trial Overview of University of Nebraska 63
Assistance Publique – Hopitaux de Paris 64
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 64
University of California, San Francisco 65
Clinical Trial Overview of University of California, San Francisco 65
University of Ottawa Heart Institute 66
Clinical Trial Overview of University of Ottawa Heart Institute 66
William Beaumont Hospitals 67
Clinical Trial Overview of William Beaumont Hospitals 67
China Academy of Chinese Medical Sciences 68
Clinical Trial Overview of China Academy of Chinese Medical Sciences 68
University of Pittsburgh 69
Clinical Trial Overview of University of Pittsburgh 69
Duke University 70
Clinical Trial Overview of Duke University 70
Vanderbilt University 71
Clinical Trial Overview of Vanderbilt University 71
Rigshospitalet 72
Clinical Trial Overview of Rigshospitalet 72
Emory University 73
Clinical Trial Overview of Emory University 73
Sheba Medical Center 74
Clinical Trial Overview of Sheba Medical Center 74
Skejby Hospital 75
Clinical Trial Overview of Skejby Hospital 75
China National Center for Cardiovascular Diseases 76
Clinical Trial Overview of China National Center for Cardiovascular Diseases 76
Kumamoto University 77
Clinical Trial Overview of Kumamoto University 77
Five Key Clinical Profiles 78
Appendix 98
Abbreviations 98
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 101
【レポート販売概要】
■ タイトル：Coronary Disease：グローバル臨床試験レビューH1, 2013■ 英文：Coronary Disease Global Clinical Trials Review, H1, 2013
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160486
■ 調査対象地域：グローバル
- 非増殖性糖尿病性網膜症(NPDR)：グローバル臨床試験動向（2014年上半期）Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2014" provides data on the Non-Proliferative Diabetic Retinopathy (NPDR) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non …
- 世界の駐車管理市場：アクセスコントロール、セキュリティ・監視、収益管理、予約管理などThe world is moving towards intelligent transportation systems, which is broadening the space for smarter ways of parking. With advanced parking management systems, the parking spots operators can offer their customers various parking conveniences such as minimal time wastage, cashless and contactless payment options, enhanced vehicle security, and options for pre-booking parking spots. The parkin …
- 中圧ケーブル・付属品の世界市場予測（～2021）The global medium voltage cables & accessories market is expected to reach USD 51.24 Billion by 2021, at a CAGR of 6.4% from 2016 to 2021. Increase in renewable energy generation, rapid industrialization & urbanization, and government initiatives undertaken to expand T&D systems would drive the market for medium voltage cables & accessories. The report segments the medium voltage cables & accessor …
- 爪真菌症(爪白癬)(Onychomycosis (Tinea Unguium))の治療薬パイプライン動向（2015年上半期版）Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, t …
- 発電管理システム（GMS）の世界市場2016-2020About Generation Management Systems (GMS) GMS are traditionally a part of the energy management systems; it is a mission critical tool that enables power companies or asset managers to manage their fleet of generation assets. GMS is a vital part of the modern power grid. It enables asset managers to optimize their assets for efficient power production and balance the profitability with risk and co …
- 骨粗鬆症：世界市場（医薬品市場予測及び分析～2022）PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022 Summary Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the ‘gold-standard’ bisphosphonates will lose patent protection by end-of-year 2013, flooding the marketplace with less expensive generic versions of these physician-preferred medication …
- ICT予算及び人員配置動向：保険産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers . What is the current market landscape and what is changing? Kable’s survey indicates that insurers are planning to increase their ICT spending in 2013 compared to 2012, with ICT investments being increasingly channelled to enterprise applications, mobility, and business …
- 北米の注射器・注射針市場見通し（～2021）North America Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "North America Syringes and Needles Market Outlook to 2021", provides key market data on the North America Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syr …
- ポリフェニレンサルファイド（PPS）の世界市場：地域別、アプリケーション別（コーティング剤、自動車、電気・電子、工業）、セグメント予測The global polyphenylene sulfide market size is expected to reach at USD 2.14 billion by 2025 expanding at a CAGR of 8.8%, according to a new report by Grand View Research, Inc. Several characteristics including high chemical and creep resistance, excellent stiffness and strength, and temperature properties of PPS are the key factors diving their demand. Automotive is projected to be the largest a …
- 配電変圧器の世界市場：乾式変圧器、油入り変圧器The global distribution transformer market is projected to reach USD 17.61 Billion by 2021, at a CAGR of 6.57% from 2016 to 2021. This growth can be attributed to capacity addition plans due to high demand for electricity and growing renewable generation leading to increased demand for distribution transformers to supply the generated power to the loads. The report segments the distribution transf …
- 照明ランプ市場（～2019）：世界市場The expansion of the global lighting product industry is forecast to reach 5.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 6.2%. Currently, electric ceiling and wall lighting fittings account for 20.2% of the global demand while the remaining market share is divided between fluorescent lamps (hot cathode) (9.4%), portable battery and magne …
- プロジェクト・ポートフォリオ管理（PPM）の世界市場2015-2019Technavio's market research analysts predict the global PPM market to grow at a CAGR of close to 12% from 2015 to 2019. Factors such as increased need for business optimization and the need to manage costs accelerate the growth of this market. PPM software solutions are used in BFSI, government, real estate, healthcare, and the retail sector to provide better visibility and management of projects. …
- グローバルホット飲料市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global hot drinks market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global hot drinks market throughout the month. Additionally, the report provides an overview of all the part …
- スタチンの世界市場2019-2023129 pages, October 2018 About this market The increasing statin use will help the market grow at a steady rate. In the US and the UK, people aged 40 and above are recommended to monitor their cholesterol level. Statins are considered an evidence-based treatment for high risk patients with elevated cardiovascular disorder. Technavio’s analysts have predicted that the statin market will register a C …
- Parex Resources Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Parex Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Parex Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
